J P Morgan Chase & Co Reiterates Neutral Rating for Smith & Nephew plc (SN)

J P Morgan Chase & Co reissued their neutral rating on shares of Smith & Nephew plc (LON:SN) in a report released on Monday, November 6th, MarketBeat.com reports. J P Morgan Chase & Co currently has a GBX 1,382 ($18.18) price target on the stock.

Several other research analysts have also recently commented on SN. reissued a hold rating and set a GBX 1,320 ($17.36) target price on shares of Smith & Nephew in a research note on Monday, July 10th. Deutsche Bank AG boosted their target price on Smith & Nephew from GBX 1,200 ($15.78) to GBX 1,315 ($17.30) and gave the stock a hold rating in a research note on Monday, October 23rd. Credit Suisse Group reaffirmed a neutral rating and set a GBX 1,280 ($16.84) price target on shares of Smith & Nephew in a report on Friday, July 28th. Jefferies Group LLC boosted their target price on Smith & Nephew from GBX 1,350 ($17.76) to GBX 1,515 ($19.93) and gave the company a buy rating in a report on Friday, July 28th. Finally, Citigroup Inc. restated a sell rating and issued a GBX 1,160 ($15.26) price target on shares of Smith & Nephew in a report on Thursday, October 12th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company. The stock has an average rating of Hold and a consensus price target of GBX 1,315.82 ($17.31).

Smith & Nephew (LON SN) traded down GBX 14 ($0.18) during midday trading on Monday, hitting GBX 1,319 ($17.35). The stock had a trading volume of 1,560,159 shares, compared to its average volume of 3,220,000. Smith & Nephew has a 1-year low of GBX 1,084 ($14.26) and a 1-year high of GBX 1,442 ($18.97).

TRADEMARK VIOLATION WARNING: This piece was posted by BBNS and is the property of of BBNS. If you are accessing this piece on another publication, it was illegally copied and republished in violation of United States & international copyright and trademark law. The legal version of this piece can be accessed at https://baseballnewssource.com/markets/smith-nephew-plc-sn-receives-neutral-rating-from-j-p-morgan-chase-co/1761447.html.

Smith & Nephew Company Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Analyst Recommendations for Smith & Nephew (LON:SN)

Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with our FREE daily email newsletter.

 


Latest News

Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Tigers Trade Ian Kinsler to Angels for Pair of Minor Leaguers
Manny Machado Could Change Positions or Uniforms
Manny Machado Could Change Positions or Uniforms
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot


Leave a Reply

 
© 2006-2017 BBNS.